OPTION EXCHANGE AGREEMENTOption Exchange Agreement • June 28th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • New Jersey
This OPTION EXCHANGE AGREEMENT, dated as of October 8, 2019 (this “Agreement”), by and between RETINALGENIX TECHNOLOGIES, INC., a Delaware corporation having an address of P.O. 2129 San Rafael, California 94912 (“RG”) and DIOPSYS, INC., a Delaware corporation having an address at 16 Chapin Road, Suite 911-912, Pine Brook, New Jersey 07058 (“DIOPSYS”). For purposes of this Agreement RG and DIOPSYS are sometimes collectively referred to as the “Parties” and individually as a “Party.”
RETINALGENIX TECHNOLOGIES INC. 2017 EQUITY INCENTIVE PLAN [as of December 1, 2017]2017 Equity Incentive Plan • June 28th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • Delaware
SUBLICENSE AGREEMENTSublicense Agreement • June 28th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • California
THIS AGREEMENT is entered into this 24th day of June, 2021 (the “Effective Date”), by and between Sanovas Ophthalmology LLC, a Nevada limited liability company having its principal office at 9120 Double Diamond Parkway, Reno NC 89521 (“Licensee”), and Retinalgenix Technologies, Inc., a corporation having its principal 1450 N. McDowell Blvd, Petaluma, CA 94954 (“Sublicensee”) (each of Licensee and Sublicensee a “Party,” and together, the “Parties”).
